CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
65.90
+0.39 (0.60%)
At close: Aug 13, 2025, 4:00 PM
66.17
+0.27 (0.41%)
Pre-market: Aug 14, 2025, 8:31 AM EDT
CVS Health Revenue
CVS Health had revenue of $98.43B in the quarter ending June 30, 2025, with 8.35% growth. This brings the company's revenue in the last twelve months to $384.33B, up 6.21% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$384.33B
Revenue Growth
+6.21%
P/S Ratio
0.22
Revenue / Employee
$1,281,097
Employees
300,000
Market Cap
83.58B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CVS News
- 1 day ago - My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys - Seeking Alpha
- 7 days ago - CVS Health Corporation (CVS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - 5 Dividend Stocks With Solid Returns And More Growth Ahead - Benzinga
- 13 days ago - CVS Targets Strong Weight-Loss Drug Use as Revenues Tick Up - PYMNTS
- 13 days ago - CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks - Benzinga
- 13 days ago - CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally. - Barrons
- 13 days ago - CVS Health Stock Soars on Strong Results, Raised 2025 Profit Outlook - Investopedia
- 14 days ago - CVS stock jumps over 8% as turnaround fuels earnings beat, outlook raised - Invezz